Oramed Pharmaceuticals Inc (ORMP)

May 25, 2026

Type 2 Diabetes Pipeline 2026: FDA Updates, Therapy - openPR.com

May 25, 2026

May 23, 2026

Oramed Pharmaceuticals (ORMP) Drops 8.9%: Support Level Under PressureInitial Balance - Newser

May 23, 2026

May 22, 2026

Oramed Pharmaceuticals: 'Hold' On Oral Insulin Drug Failure Pivot And New Strategic Investment Direction - Seeking Alpha

May 22, 2026

May 22, 2026

ORMP Should I Buy - Intellectia AI

May 22, 2026

May 20, 2026

Oramed Pharmaceuticals Inc. Q1 2026 Financial Report: Key Investments, Marketable Securities, and Forward-Looking Statements - Minichart

May 20, 2026

May 19, 2026

Oramed: Q1 Earnings Snapshot - marketscreener.com

May 19, 2026

May 19, 2026

ORAMED PHARMACEUTICALS INC. 1Q 2026: Revenue $0 Net income $38.31M, EPS $0.91— 10-Q Summary - TradingView

May 19, 2026

May 19, 2026

Oramed (NASDAQ: ORMP) swings to $38.3M Q1 profit on Alpha Tau and Scilex gains - Stock Titan

May 19, 2026

May 19, 2026

Oramed Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 19, 2026

May 18, 2026

Lifeward Ltd.16079622026 - SEC.gov

May 18, 2026

May 15, 2026

Oramed Pharmaceuticals (ORMP) Q4 2025 Financial OverviewIncome Pick - newser.com

May 15, 2026

May 15, 2026

Oramed Pharmaceuticals Delays Quarterly SEC Filing - TipRanks

May 15, 2026

May 15, 2026

Oramed Pharmaceuticals (NASDAQ: ORMP) notifies late Q1 2026 Form 10-Q filing - Stock Titan

May 15, 2026

May 15, 2026

About Us | Oil & Gas JournalOramed Pharmaceuticals Inc.Common Stock (Nasdaq:ORMP) Stock Quote - FinancialContent

May 15, 2026

May 15, 2026

Oramed Pharmaceuticals (ORMP) Stock: Slides -0.74%, Support at $4.46 2026-05-15Buy Signals - newser.com

May 15, 2026

May 15, 2026

Aquamarine reports 5.06% stake in Oramed (ORMP) via Schedule 13G - Stock Titan

May 15, 2026

May 14, 2026

Oramed Pharmaceuticals Discloses Investment at Lifeward with 49.9% Stake - TradingView

May 14, 2026

May 14, 2026

Oramed details Lifeward (LFWD) equity stake, notes and warrants - Stock Titan

May 14, 2026

May 14, 2026

Oramed (LFWD) reports 49.9% Lifeward stake, $9M notes and warrants - Stock Titan

May 14, 2026

May 14, 2026

Oramed Pharmaceuticals stock (US68403P1003): Oral drug delivery innovator for US diabetes market - AD HOC NEWS

May 14, 2026

May 13, 2026

Spotlight On Oramed Pharmaceuticals And Two Other Prominent Penny Stocks - Yahoo Finance

May 13, 2026

May 12, 2026

Oramed Pharmaceuticals stock (US68403P1003): Shares surged 7.98% to $2.30 - AD HOC NEWS

May 12, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 11, 2026

MSN Money - MSN

May 11, 2026

May 01, 2026

ORMP News | ORAMED PHARMACEUTICALS INC (NASDAQ:ORMP) - ChartMill

May 01, 2026

Apr 27, 2026

NNDM stock in focus: Nano Dimension pops a poison pill days after Oramed stake build-up - MSN

Apr 27, 2026

Apr 23, 2026

ORMP (Oramed Pharmaceuticals) falls 2.84% after releasing Q4 2025 earnings with no prior analyst consensus estimates.Current Ratio - Xã Thanh Hà

Apr 23, 2026

Apr 22, 2026

ORMP (Oramed Pharmaceuticals Inc.) rises 0.53 percent following release of its 2025 fourth quarter earnings results.Debt/Equity - Xã Thanh Hà

Apr 22, 2026

Apr 16, 2026

Oramed Pharmaceuticals (ORMP) Stock Rally Stalls (+1.05%) 2026-04-16Shared Momentum Picks - Xã Vĩnh Công

Apr 16, 2026

Apr 14, 2026

Oramed Pharmaceuticals And Two Other Promising Penny Stocks For Savvy Investors - Yahoo Finance

Apr 14, 2026

Apr 13, 2026

Evolus and Oramed Pharmaceuticals Compared - National Today

Apr 13, 2026

Apr 10, 2026

Setup Watch: Is Oramed Pharmaceuticals Inc stock technically oversold2026 Opening Moves & Daily Profit Focused Stock Screening - baoquankhu1.vn

Apr 10, 2026

Apr 09, 2026

Sell Signal: What is Oramed Pharmaceuticals Incs 5 year growth outlookEarnings Overview Summary & AI Powered Trade Plan Recommendations - baoquankhu1.vn

Apr 09, 2026

Apr 08, 2026

Fund Flows: Can Oramed Pharmaceuticals Inc keep up with sector leadersMarket Performance Summary & Safe Entry Momentum Stock Tips - baoquankhu1.vn

Apr 08, 2026

Apr 08, 2026

Technical Analysis: Will Oramed Pharmaceuticals Inc face regulatory challenges2026 Earnings Impact & Growth Oriented Trading Recommendations - baoquankhu1.vn

Apr 08, 2026

Apr 08, 2026

Lifeward scoops US$20M after completing Oratech Pharma takeover - Mugglehead Investment Magazine

Apr 08, 2026

Apr 07, 2026

Oramed Pharmaceuticals (NASDAQ:ORMP) Share Price Passes Above 50-Day Moving AverageHere's What Happened - MarketBeat

Apr 07, 2026

Apr 04, 2026

ORMP Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Apr 04, 2026

Apr 03, 2026

Oramed Pharmaceuticals stock: Oral insulin pioneer or high-risk bet? - AD HOC NEWS

Apr 03, 2026

Apr 03, 2026

INO Stock Analysis: Inovio Pharmaceuticals Inc. plunges 35% to $1.13 biotech support level - Xã Thanh Hà

Apr 03, 2026

Apr 02, 2026

ORMP Q4 Earnings: Beats Estimates by $1.16 - newser.com

Apr 02, 2026

Apr 01, 2026

Oramed Completes Oratech Sale and Strategic Lifeward Financing - The Globe and Mail

Apr 01, 2026

Apr 01, 2026

ABOS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 01, 2026

Mar 31, 2026

Oramed (ORMP) completes Oratech sale and buys $9M Lifeward notes - Stock Titan

Mar 31, 2026

Mar 31, 2026

Oramed (NASDAQ: ORMP) CSO uses 435,084 shares to cover RSU tax - Stock Titan

Mar 31, 2026

Mar 31, 2026

Oramed (NASDAQ: ORMP) CEO uses 44,818 shares to cover RSU tax withholding - Stock Titan

Mar 31, 2026